Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')2 fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study

2015 ◽  
Vol 15 (3) ◽  
pp. 285-292 ◽  
Author(s):  
Céline Bal ◽  
Cécile H Herbreteau ◽  
Philippe Buchy ◽  
Sareth Rith ◽  
Masliza Zaid ◽  
...  
Keyword(s):  
Avian Influenza ◽  
Healthy Volunteers ◽  
Influenza A ◽  
Phase 1 ◽  
Single Centre ◽  
Phase 1 Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Potential Efficacy ◽  
Polyclonal Immunoglobulin

P4-381: A Two-Part, Double-Blind, Placebo-Controlled, Phase 1 Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of CT1812 in Healthy Volunteers

2016 ◽  
Vol 12 ◽  
pp. P1183-P1184
Author(s):  
Susan Catalano ◽  
Michael Grundman ◽  
Lon S. Schneider ◽  
Steven DeKosky ◽  
Roger Morgan ◽  
...  
Keyword(s):  
Healthy Volunteers ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

The Lancet ◽  
2019 ◽  
Vol 394 (10193) ◽  
pp. 148-158 ◽  
Author(s):  
Pierre Van Damme ◽  
Ilse De Coster ◽  
Ananda S Bandyopadhyay ◽  
Hilde Revets ◽  
Kanchanamala Withanage ◽  
...  
Keyword(s):  
Phase 1 ◽  
Healthy Adults ◽  
Single Centre ◽  
Phase 1 Study ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document